Ophthalmology Times Europe January / February 2021

January / February 2021

Investigators explore pathogenic cytokines as biomarkers for DMO

January 27, 2021

Results of a study analysing cytokine levels in the aqueous humour and serum of patients with nonproliferative diabetic retinopathy with and without diabetic macular oedema support further research investigating transforming growth factor-β-induced Gene Human Clone 30 (BIGH3) as a potential biomarker for DMO.

Non-linear aspheric corneal ablation can be used to treat presbyopia

January 18, 2021

Presbyopia can be treated in emmetropic, myopic and hyperopic patients with refractive errors between +5.75 and -9.00 D using corneal non-linear aspheric ablation profiles to increase the depth of field in both eyes, in combination with micro-monovision. Patient satisfaction with this approach is high.

Risks and management of diabetic retinopathy in paediatric patients

January 13, 2021

Diabetes mellitus, which is a common chronic disease in children, can lead to significant eye morbidities with long-lasting effects, including diabetic retinopathy. Treatment should be tailored to the individual patient.